Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6077603 | 0.79 | — | — | |
| SCHEMBL6722103 | 0.79 | — | — | |
| SCHEMBL12556842 | 0.79 | — | — | |
| SCHEMBL15026862 | 0.79 | — | — | |
| SCHEMBL6719995 | 0.77 | — | — | |
| SCHEMBL16566061 | 0.77 | — | — | |
| SCHEMBL6719992 | 0.77 | — | — | |
| SCHEMBL800723 | 0.72 | CA1 (0.55) | BLMCA1 | |
| SCHEMBL20999895 | 0.72 | CA1 (0.36) | BLMCA1 | |
| SCHEMBL14481257 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9765003-B2 | Process for producing 2,6-dimethyl-5-hepten-1-al | BASF SE (DE) | 2017-09-19 | — | — | US | disclosed |
| US-9765003-B2 | Process for producing 2,6-dimethyl-5-hepten-1-al | BASF SE (DE) | 2017-09-19 | — | — | US | disclosed |
| US-20170183280-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2017-06-29 | — | — | US | disclosed |
| US-20170183280-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2017-06-29 | — | — | US | disclosed |
| WO-2015169721-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2015-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170183280-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | CYP8B1, CYP51A1, MSMO1 | TSHR 4850/4885SLC6A2 4780/4885SLC6A4 4771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.